IPP Bureau
Sun Pharma introduces Ilumya in India for treatment of plaque psoriasis
By IPP Bureau - December 01, 2025
Ilumya is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase 3 efficacy and safety extension trials
Lupin receives FDA approval for biosimilar Armlupeg
By IPP Bureau - December 01, 2025
Armlupeg is indicated for decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs
Roche expands Veeva partnership with global rollout of AI-driven Vault CRM
By IPP Bureau - December 01, 2025
Roche says the move marks a step forward in its digital transformation strategy
OSR Holdings moves towards major licensing deal for oral cancer immunotherapy
By IPP Bureau - December 01, 2025
Under the proposed terms, Vaximm would secure a $20 million upfront payment, up to $815 million tied to clinical, regulatory, and commercial milestones
LANXESS unveils next-gen biosecurity solutions for Indian poultry market at Poultry Expo
By IPP Bureau - December 01, 2025
LANXESS Biosecurity Solutions aims to deliver “advanced disinfection and hygiene solutions to support Indian farmers in maintaining healthier and safer farm environments
Sudapack breaks ground on major PharmaGuard expansion in Erolzheim
By IPP Bureau - December 01, 2025
Phase one of the expansion will convert an existing hall into an ISO 7-certified cleanroom for GMP-compliant production
Global measles deaths plunge but cases surge, says WHO
By IPP Bureau - December 01, 2025
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
SciSparc acquires Xylo Technologies' innovative endoscopic portfolio
By IPP Bureau - December 01, 2025
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
SK Biopharmaceuticals acquires exclusive global rights for WARF cancer drug candidate
By IPP Bureau - December 01, 2025
Feinstein Institutes awarded $3.37 million grant to boost first responder mental health
By IPP Bureau - December 01, 2025
The study, titled “A Large-Scale Efficacy Trial of a Resilience Training Program for First Responders,” will enroll 800 first responders in New York and Texas
Lung Cancer Canada and Boehringer Ingelheim team up to transform lung cancer detection
By IPP Bureau - December 01, 2025
Selected proposals in the innovation challenge will receive funding to develop transformative ideas, tools, and approaches to strengthen early diagnosis and improve patient outcomes
GE HealthCare launches game-changing StarGuide GX for precision nuclear medicine
By IPP Bureau - December 01, 2025
StarGuide GX delivers ultra-high sensitivity and high-resolution imaging, enabling fast, confident diagnostics
Granules India opens advanced Centres of Excellence in Hyderabad
By IPP Bureau - December 01, 2025
Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides
SAI Parenteral's acquires Australia's Noumed Pharmaceuticals for Rs. 125 Cr
By IPP Bureau - December 01, 2025
MHRA clears inavolisib, offering new option for returning breast cancer
By IPP Bureau - November 30, 2025
The oral, film-coated tablet is licensed for patients whose cancer has returned during or shortly after hormone therapy
